CPA3 is a kind of metallo-carboxypeptidase that modulates inflammation, fibrosis, and stem cell niche formation in liver cancer [39], whose overexpression might associate with worse grades, stages, and prognosis of patients [40]. Here, CPA3 is linked to liver cancer.